A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

The quantum Internet can be a mind-bending, sci-fi sounding concept, but it’s also one that is getting closer, albeit slowly, ...

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

New blood tests promise to detect malignancies before they’ve spread. But proving that these tests actually improve outcomes remains a stubborn challenge.

With CT scans picking up more cases of sclerosing mesenteritis, be prepared to diagnose this poorly understood autoimmune ...

A team of researchers is tapping into the ocean’s vast body of free-floating environmental DNA to catch blooms before they ...

Oral cancer, which includes malignancies affecting the lips, tongue, gums, cheeks, and floor of the mouth, represents a ...

Looking back on testing & diagnostics services stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Labcorp (NYSE:LH) and its peers. The testing and diagnostics services ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

Located billions of light-years away, the "Cosmic Owl" is a pair of colliding ring galaxies spotted by the JWST. It's also an "exceptional natural laboratory" for studying how galaxies evolve.